An intensive 2-day meeting that delves into the latest in antibody engineering and antibody-based therapeutics & a meeting place for experts working within engineering, computational tools and antibody-based therapeutics.

Benefits to Attending

Hear from and meet with the leading figures in the antibody, ADC and bispecifics engineering antibody-based therapeutics; offering in-depth presentations and new inspiring ideas to advance your research

Engage in in-depth panel discussions, roundtables and workshops brining together like-minded experts to address the pressing challenges & opportunities of the market

Explore case studies including antibody gene therapy and developing antibody therapies aiding the treatment of Covid-19

Agenda at a Glance

Day One

AI/ML & Emerging Technologies in Antibody-based Molecular Engineering

• In silico engineering of antibodies 
• Engineering antibody-based therapeutics with improved drug-like properties 

• Designing and engineering of new and required antibodies 
• AI/ML in antibody engineering 
• In vivo antibody expression  
• Alternative modalities & antibody fragments 

Day Two

Towards Optimising Antibody-Based Therapeutics and Modes of Action

• New strategies & methods in handling novel & difficult targets 
• Transforming targets for antibody-based therapeutics 
• Assessing target specificity
• Fc engineering